TransCode Therapeutics Announces Withdrawal of Registration Statement
06.12.2022 - BOSTON, Dec. 06, 2022 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it withdrew the Registration ...